Company*
(Country;
Symbol)

Company*

Type/Product Area

Terms/Details (Date)


Biotique Systems Inc.*

Affymetrix Inc. (AFFX)

Affymetrix licensed the Biotique Local Integration System, a data integration solution

Affymetrix will use the system in its research activities; terms were not disclosed (11/11)

Celsion Corp. (AMEX:CLN)

Asia Pacific Life Sciences Corp. Ltd. (China)

Joint venture to develop and distribute Celsion's products in China

Asia Pacific Life Sciences is a group of Hong Kong-based investors; terms of the deal were not disclosed (12/15)

Epoch Biosciences Inc. (EBIO)

BioControl Systems Inc.*

Nonexclusive license to Epoch's MGB Eclipse technologies

BioControl will use the technology in the area of food testing; Epoch will get access fees, revenues on product sales and royal- ties on resulting end-system sales (10/28)

Locus Pharmaceuticals Inc.*

IBM Corp.

Collaboration to deploy supercomputing power for research and drug design

Locus will leverage the additional computing power to improve research efficiency; a focus is Locus' program in HIV and AIDS (12/2)

Panacea Pharmaceuticals Inc.*

JSR Corp. (Japan)

To develop and improve assays in Panacea's HAAH oncology program

JSR will provide capabilities in magnetic particle fabrication and surface chemistries; terms were not disclosed (12/9)

Parallel Solutions Inc.*

Phase III Medical Inc. (OTC BB:PHSM)

Royalty agreement for a bioshielding technology with improved delivery of small and large molecules

PSI would pay Phase III a percentage of revenue from the technology in exchange for capital and guidance provided by Phase III (12/12)


Notes:

# This chart does not include agreements that involve agricultural product development.

* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board.

No Comments